Probiotic Possibilities In Crohn’s Disease: A Research Review Article


  • Abhinav Vijay Dougherty Valley High School
  • Alvin Han Stanford University, Polygence



Probiotics, Crohn's Disease, Clinical Trials, Review Article, Possibilites of Probiotics


Crohn’s Disease (CD) is a chronic autoimmune disease in the Inflammatory Bowel Disease (IBD) family.  The presence of certain pathogenic bacteria can cause the disease, but so can the absence of helpful ones. The microorganisms in the gut microbiome carry out many vital tasks, and with missing bacteria these tasks are not carried out. Main treatments for CD are: immunosuppressants, anti-inflammatory drugs, steroids, antibacterial drugs, and biologics, each one offers particular benefits and harmful side effects. Treatments have increased the chances of developing cancers, and illnesses, since the immune system is oftentimes compromised. In a healthy individual these microbes play a large part in our bodies, protecting us from pathogens, “teaching” the immune system, aiding in digestion and improving nutrient absorption. In CD patients the microbial composition in the gut microbiome is unbalanced, introduction of probiotics would bring balance back to the gut. All clinical trials performed so far gave patients the same formula of probiotics. However, each individual has a unique microbiome composition, which these trials failed to take into consideration. Considering this, a possible treatment plan may require a multi-strain probiotic treatment that is tailor fitted for each individual. Therefore, moving forward clinical trials should test tailor fitted probiotic formulas, which could show more promising results.



Download data is not yet available.

Author Biography

Alvin Han, Stanford University, Polygence


References or Bibliography

About crohn's disease. (n.d.). Retrieved January 13, 2022, from,Crohn's%20disease%20is%2035%20percent.

Bertani, B., & Ruiz, N. (2018, August). Function and biogenesis of lipopolysaccharides. EcoSal Plus. Retrieved January 13, 2022, from

Clinic, 1C. (n.d.). True or false? the hygiene hypothesis for crohn's disease : Official Journal of the American College of Gastroenterology: ACG. LWW. Retrieved January 13, 2022, from's,likely%20to%20develop%20Crohn's%20disease.

Harvard. (2020, May 1). The microbiome. The Nutrition Source. Retrieved January 13, 2022, from

Cirino, E. (2020, October 2). Is Crohn's Disease genetic? statistics and more. Healthline. Retrieved February 15, 2022, from,immediate%20relative%20with%20the%20disease.

Smoking and IBD: Crohn's & colitis UK. Smoking and Crohn's or Colitis | Crohn's & Colitis UK. (n.d.). Retrieved February 15, 2022, from's,smoking%20can%20make%20Crohn's%20worse.&text=Research%20suggests%20that%20women%20who,surgery%2C%20than%20men%20who%20smoke.

Feldman, L. (2021, March 15). Does smoking, alcohol, or coffee put you at risk for crohn's disease or ulcerative colitis? Crohn's & Colitis Foundation. Retrieved February 15, 2022, from

MD Anderson Cancer Center, & Underferth, D. (2021, April 8). Does crohn's disease affect your cancer risk? MD Anderson Cancer Center. Retrieved February 15, 2022, from

Poggioli, G., Laureti, S., Campieri, M., Pierangeli, F., Gionchetti, P., Ugolini, F., Gentilini, L., Bazzi, P., Rizzello, F., & Coscia, M. (2007, June). Infliximab in the treatment of crohn's disease. Therapeutics and clinical risk management. Retrieved February 15, 2022, from

Mayo Foundation for Medical Education and Research. (2020, October 13). Crohn's disease. Mayo Clinic. Retrieved February 15, 2022, from

Thursby, E., & Juge, N. (2017, May 16). Introduction to the human gut microbiota. The Biochemical journal. Retrieved February 15, 2022, from

Bull, M. J., & Plummer, N. T. (2014, December). Part 1: The human gut microbiome in health and disease. Integrative medicine (Encinitas, Calif.). Retrieved February 15, 2022, from,type%202%20diabetes%2C%20and%20atopy.

Bertani, B., & Ruiz, N. (2018, August). Function and biogenesis of lipopolysaccharides. EcoSal Plus. Retrieved February 15, 2022, from

Koloski, N.-A., Bret, L., & Radford-Smith, G. (2008, January 14). Hygiene hypothesis in inflammatory bowel disease: A critical review of the literature. World journal of gastroenterology. Retrieved February 16, 2022, from

Ledder, O. (2019, January). Antibiotics in inflammatory bowel diseases: Do we know what we're doing? Translational pediatrics. Retrieved February 16, 2022, from

Bjarnason, I., Sission, G., & Hayee, B. H. (2019, June). A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and crohn's disease. Inflammopharmacology. Retrieved February 17, 2022, from



How to Cite

Vijay, A., & Han, A. (2022). Probiotic Possibilities In Crohn’s Disease: A Research Review Article. Journal of Student Research, 11(2).



HS Review Articles